Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
0013, 0025, 0069, 60793, 72618
Strengths (from the 100 most recently listed products)
Doxorubicin hydrochloride 2 mg/mL; Human immunoglobulin g 100 mg/mL; Human immunoglobulin g 165 mg/mL; Human immunoglobulin g 50 mg/mL; Amlodipine besylate 5 mg/1; Amlodipine besylate 10 mg/1; Propofol 10 mg/mL; Marstacimab 150 mg/mL; Talazoparib tosylate .5 mg/1; Atorvastatin calcium trihydrate 80 mg/1; Atorvastatin calcium trihydrate 20 mg/1; Atorvastatin calcium trihydrate 40 mg/1; Atorvastatin calcium trihydrate 10 mg/1; Rimegepant sulfate 75 mg/1; Thrombin 5000 [iU]/5mL; Bnt-162b2 omicron (Xfg) mrna .0158 mg/.48mL; Bnt-162b2 omicron (Xfg) mrna .042 mg/.418mL; Marstacimab 75 mg/.5mL; Thrombin 20000 [iU]/20mL; Leucovorin calcium 5 mg/1
Dosage forms
Injection, Solution, Solution, Tablet, Film coated, Kit, Capsule, Liquid filled, Injection, Suspension, Capsule, Capsule, Coated pellets, Injection, Injection, Emulsion, Liquid, Injection, Powder, Lyophilized, For solution, Tablet, Orally disintegrating, Tablet, System, Spray, Tablet, Film coated, Extended release
Routes
Oral, Intravenous, Subcutaneous, Intramuscular, Topical, Vaginal, Nasal
Drug classes (FDA established)
Human Immunoglobulin G, Anthracycline Topoisomerase Inhibitor, Kinase Inhibitor, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, HMG-CoA Reductase Inhibitor, Poly(ADP-Ribose) Polymerase Inhibitor, Janus Kinase Inhibitor, Calcitonin Gene-related Peptide Receptor Antagonist, General Anesthetic, Blood Coagulation Factor, Recombinant Human Growth Hormone, Erythropoiesis-stimulating Agent, CD20-directed Cytolytic Antibody, Vascular Endothelial Growth Factor Inhibitor, Folate Analog, Sphingosine 1-phosphate Receptor Modulator, Estrogen, Anti-coagulant, Low Molecular Weight Heparin, HER2/neu Receptor Antagonist, Leukocyte Growth Factor
Package NDCs
108 (from the 100 most recently listed products)

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Pfizer Laboratories Div Pfizer Inc NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
Thrombin-Jmithrombin, topical (bovine)Thrombin 5000 [iU]/5mLLiquidTopical60793-33360793-0333-01—
Comirnatycovid-19 vaccine, mrnaBnt-162b2 omicron (Xfg) mrna .0158 mg/.48mLInjection, SuspensionIntramuscular0069-260900069-2609-10—
Comirnatycovid-19 vaccine, mrnaBnt-162b2 omicron (Xfg) mrna .042 mg/.418mLInjection, SuspensionIntramuscular0069-263100069-2631-10—
Hympavzimarstacimab-hncqMarstacimab 75 mg/.5mLInjection, SolutionSubcutaneous0069-077500069-0775-01—
Thrombin-Jmithrombin, topical (bovine)Thrombin 20000 [iU]/20mLLiquidTopical60793-02060793-0020-01—
Paxlovidnirmatrelvir and ritonavir—Kit0069-545000069-5450-11—
Lederle Leucovorincalcium folinateLeucovorin calcium 5 mg/1TabletOral0069-588600069-5886-2400069-5886-99—
Hympavzimarstacimab-hncqMarstacimab 150 mg/mLInjection, SolutionSubcutaneous0069-151000069-1510-01—
Comirnatycovid-19 vaccine, mrnaBnt162b2 omicron (LP.8.1) .0158 mg/.48mLInjection, SuspensionIntramuscular0069-250100069-2501-10—
Comirnatycovid-19 vaccine, mrnaBnt162b2 omicron (LP.8.1) .042 mg/.418mLInjection, SuspensionIntramuscular0069-252800069-2528-10—
Paxlovidnirmatrelvir and ritonavir—Kit0069-504500069-5045-30—
Paxlovidnirmatrelvir and ritonavir—Kit0069-543400069-5434-20—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-562900069-5629-05—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-403100069-4031-12—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-420500069-4205-05—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-034300069-0343-02—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-335800069-3358-25—
Hympavzimarstacimab-hncqMarstacimab 150 mg/mLInjection, SolutionSubcutaneous0069-215100069-2151-01—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-025500069-0255-10—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-144200069-1442-04—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-035800069-0358-20—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-027700069-0277-02—
Abrysvorespiratory syncytial virus vaccineRecombinant stabilized rsv a prefusion f antigen .06 mg/.5mL; Recombinant stabilized rsv b prefusion f antigen .06 mg/.5mLInjection, Powder, Lyophilized, For solutionIntramuscular0069-246500069-2465-0100069-2465-10—
Doxorubicin HydrochlorideDoxorubicin hydrochloride 2 mg/mLInjection, SolutionIntravenous0069-154200069-1542-20—
TalzennatalazoparibTalazoparib tosylate .35 mg/1Capsule, Liquid filledOral0069-045400069-0454-30—
TalzennatalazoparibTalazoparib tosylate .75 mg/1Capsule, Liquid filledOral0069-065500069-0655-30—
TalzennatalazoparibTalazoparib tosylate .1 mg/1Capsule, Liquid filledOral0069-025200069-0252-30—
TalzennatalazoparibTalazoparib tosylate .5 mg/1Capsule, Liquid filledOral0069-054600069-0546-30—
TalzennatalazoparibTalazoparib tosylate .25 mg/1Capsule, Liquid filledOral0069-035300069-0353-30—
TalzennatalazoparibTalazoparib tosylate 1 mg/1Capsule, Liquid filledOral0069-075700069-0757-30—
BosulifbosutinibBosutinib monohydrate 50 mg/1CapsuleOral0069-050400069-0504-30—
BosulifbosutinibBosutinib monohydrate 100 mg/1CapsuleOral0069-101400069-1014-15—
Abriladaadalimumab-afzb—Kit0025-033300025-0333-02—
Abriladaadalimumab-afzb—Kit0025-032500025-0325-0100025-0325-02—
Abriladaadalimumab-afzb—Kit0025-032800025-0328-02—
Penbrayameningococcal groups a, b, c, w, and y vaccine—Kit0069-060000069-0600-0100069-0600-0500069-0600-10—
XalkoricrizotinibCrizotinib 20 mg/1Capsule, Coated pelletsOral0069-025100069-0251-60—
XalkoricrizotinibCrizotinib 150 mg/1Capsule, Coated pelletsOral0069-150000069-1500-60—
XalkoricrizotinibCrizotinib 50 mg/1Capsule, Coated pelletsOral0069-050700069-0507-60—
Octagam Immune Globulin (Human)immune globulinHuman immunoglobulin g 50 mg/mLSolutionIntravenous0069-845100069-8451-02—
Octagam Immune Globulin (Human)immune globulinHuman immunoglobulin g 100 mg/mLSolutionIntravenous0069-611100069-6111-02—
Octagam Immune Globulin (Human)immune globulinHuman immunoglobulin g 50 mg/mLSolutionIntravenous0069-840000069-8400-02—
Octagam Immune Globulin (Human)immune globulinHuman immunoglobulin g 100 mg/mLSolutionIntravenous0069-655000069-6550-02—
Octagam Immune Globulin (Human)immune globulinHuman immunoglobulin g 50 mg/mLSolutionIntravenous0069-847600069-8476-02—
Octagam Immune Globulin (Human)immune globulinHuman immunoglobulin g 50 mg/mLSolutionIntravenous0069-842500069-8425-02—
Octagam Immune Globulin (Human)immune globulinHuman immunoglobulin g 100 mg/mLSolutionIntravenous0069-600200069-6002-02—
Octagam Immune Globulin (Human)immune globulinHuman immunoglobulin g 100 mg/mLSolutionIntravenous0069-633900069-6339-02—
Octagam Immune Globulin (Human)immune globulinHuman immunoglobulin g 100 mg/mLSolutionIntravenous0069-623700069-6237-02—
VelsipityetrasimodEtrasimod arginine 2 mg/1Tablet, Film coatedOral0069-027400069-0274-30—
Paxlovidnirmatrelvir and ritonavir—Kit0069-531700069-5317-20—

Pfizer Laboratories Div Pfizer Inc: common questions

What is Pfizer Laboratories Div Pfizer Inc's NDC labeler code?
0013, 0025, 0069, 60793, 72618. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for Pfizer Laboratories Div Pfizer Inc?
Med-Code's HCPCS directory matches CPT 90678, J9355, J2506, J9312, J9035 to these products. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in